Chembio Diagnostics, Inc.
Built from real-time financials, refreshed daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a CEMI research report →
About the company
Chembio Diagnostics, Inc. , along with its subsidiaries, specializes in creating, producing, and bringing to market point-of-care (POC) diagnostic tests used for identifying and diagnosing various diseases. Their current product offerings include tests for critical conditions like COVID-19, HIV/Syphilis, and the Zika virus.
- CEO
- Richard L. Eberly
- IPO
- 2000
- Employees
- 188
- HQ
- Hauppauge, NY, US
Price Chart
- Market Cap
- $16.71M
- P/E
- -0.47
- P/S
- 0.35
- P/B
- 0.62
- EV/EBITDA
- -1.62
- Div Yield
- 0.00%
- Gross Margin
- 20.19%
- Op Margin
- -42.21%
- Net Margin
- -48.18%
- ROE
- -89.47%
- ROIC
- -47.58%
- Revenue
- $48.34M · 30.91%
- Net Income
- $-23,290,657 · 31.30%
- EPS
- $-0.96 · 31.43%
- Op Income
- $-20,401,861
- FCF YoY
- 56.80%
- 52W High
- $1.24
- 52W Low
- $0.19
- 50D MA
- $0.43
- 200D MA
- $0.44
- Beta
- 1.86
- Avg Volume
- 538.39K
Get TickerSpark's AI analysis on CEMI
Create an account to generate AI analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →Already have an account? Log in
Recent insider transactions
Who's buying, who's selling, and how much.
| Date | Insider | Type | Shares |
|---|---|---|---|
| Mar 11, 23 | Angelico Paul | other | 29,333 |
| Mar 15, 23 | Angelico Paul | other | 7,885 |
| Mar 15, 23 | Angelico Paul | other | 2,843 |
| Mar 11, 23 | Angelico Paul | other | 10,575 |
| Mar 11, 23 | Angelico Paul | other | 29,333 |
| Oct 28, 22 | Angelico Paul | other | 10,594 |
| Oct 28, 22 | Angelico Paul | other | 3,823 |
| Mar 15, 23 | Angelico Paul | other | 7,885 |
| Apr 27, 23 | Angelico Paul | sell | 66,553 |
| Apr 27, 23 | Angelico Paul | sell | 177,080 |
Our CEMI coverage
Recent articles, reports, and earnings notes.
No research on CEMI yet
For a full analyst-grade research report — grades, price targets, financials, chart analysis — generate one on demand.
Generate CEMI report →Similar companies
Peers in the same neighborhood.